pubmed.ncbi.nlm.nih.gov
T cell malignancies after CAR T cell therapy in the DESCAR-T registry - PubMed
The risk of T cell malignancies after chimeric antigen receptor (CAR) T cell therapy is a concern, although the true incidence remains unclear. Here we analyzed the DESCAR-T registry database, encompa...